← 返回

流式细胞术评估效应免疫细胞对肿瘤细胞的细胞毒性

英文原题:Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cells.

查看英文原题

Flow cytometry evaluation of cytotoxicity exerted by effector immune cells against tumor cells.

PubMed 2026/02/25(内容时间) Methods Cell Biol

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

基于免疫效应细胞——自然杀伤(NK)细胞、细胞毒性T淋巴细胞(CTL)——的过继性细胞疗法是治疗耐药肿瘤,尤其是管理血液系统恶性肿瘤的一种有前景的方法。该领域的快速发展凸显了对可靠体外方法的需求,以评估针对所需靶细胞所开发的细胞产品的细胞毒性潜力,其中许多靶细胞是悬浮细胞,因此带来了额外的技术挑战。在此,我们提出了一种基于流式细胞术的方案,用于定量与免疫效应细胞共培养后的肿瘤细胞死亡。与早期技术相比,该方法能够识别靶细胞并定量其基础凋亡死亡和效应细胞诱导的凋亡死亡。所描述的方案具有高度适应性,使其适用于研究脆弱或有限的患者样本、评估与药物或抗体的联合疗法,以及分析额外的细胞标志物或细胞死亡机制。总之,该方案提供了一种检测设置和设门策略,能够产生精确且可重复的数据,这对于过继性细胞疗法的优化至关重要。

展开英文摘要原文

Adoptive cell therapies based on immune effector cells - Natural Killer (NK) cells, Cytotoxic T Lymphocytes (CTL) - represent a promising approach for the treatment of resistant tumors, especially for the management of hematological malignancies. The rapid growth of this field emphasises the need for reliable in vitro methods to evaluate the cytotoxic potential of the cell products developed against the desired target cells, many of which are cells in suspension and consequently pose additional technical challenges.

Here, we present a flow-cytometry-based protocol for the quantification of tumor cell death after co-culture with immune effector cells. Compared to earlier techniques, this approach allows for the identification of target cells and quantification of both their basal and effector cell-induced apoptotic death.

The protocol described is highly adaptable, making it suitable for the study of fragile or limited patient samples, the evaluation of combination therapies with drugs or antibodies, and for the analysis of additional cellular markers or cell death mechanisms. Altogether, the protocol provides an assay setup and gating strategy that generate precise and reproducible data, essential for adoptive cell therapy optimization.

论文信息

作者
Ripollés-Yuba C、Giraldos D、Galano-Frutos E、Reina-Ortiz C、Anel A
第一作者单位
Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute, Biochemistry and Molecular and Cell Biology, University of Zaragoza, Zaragoza, Spain.Spain
通讯作者单位
Apoptosis, Immunity and Cancer Group, Aragón Health Research Institute, Biochemistry and Molecular and Cell Biology, University of Zaragoza, Zaragoza, Spain. Electronic address: anel@unizar.es.Spain
期刊
Methods in cell biology2026
原文标识
PubMed 42276713 · DOI 10.1016/bs.mcb.2026.02.008